886499-40-7

Usage

Uses

Used in Pharmaceutical Industry:
2-CHLORO-6-FLUORO-3-METHOXYBENZOIC ACID is used as an intermediate in the synthesis of pharmaceuticals for its versatile chemical properties. It aids in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
2-CHLORO-6-FLUORO-3-METHOXYBENZOIC ACID is used as an intermediate in the synthesis of agrochemicals to develop crop protection products. Its unique structure contributes to the creation of effective agents for agricultural use.

Upstream product

• 124-38-9 carbon dioxide 
• 2267-25-6 2-chloro-4-fluoro-1-methoxy-benzene 

Downstream Products

• 1017777-58-0 2-chloro-6-fluoro-3-methoxy-aniline 
• 1427407-23-5 3-amino-2-chloro-4-fluoro-phenol 
• 1427407-24-6 N-(2-chloro-6-fluoro-3-hydroxy-phenyl)-2-fluoro-5-(3-fluorophenyl)benzamide 
• 1427407-25-7 2-chloro-4-fluoro-3-[[2-fluoro-5-(3-fluorophenyl)phenyl]methylamino]phenol 
• 1427407-26-8 C₂₃H₁₉ClF₃NO₃ 
• 1427406-15-2 2-[2-chloro-4-fluoro-3-[[2-fluoro-5-(3-fluorophenyl)phenyl]methylamino]phenoxy]acetic acid 
• 1616290-37-9 4-((2-benzyloxy-4,6-dimethylpyridin-3-yl)methyl)-6-chloro-7-methoxy-3,4-dihydrobenzo[f ][1,4]oxazepin-5(2H)-one 
• 1616290-35-7 N-{[2-(benzyloxy)-4,6-dimethylpyridin-3-yl]methyl}-2-chloro-6-fluoro-N-(2-hydroxyethyl)-3-methoxybenzamide 

Relevant academic research and scientific papers

ANILINE DERIVATIVES,THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

The present invention relates to aniline derivatives, to their preparation and to their therapeutic application.

PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK' S AND GSK' S

The invention provides compounds of the formula (I), or salts, tautomers, N-oxides or solvates thereof wherein: R1 is selected from: (a) 2,6-dichlorophenyl; (b) 2,6-difluorophenyl; (c) a 2,3,6-trisubstituted phenyl group wherein the substituents for the phenyl group are selected from fluorine, chlorine, methyl and methoxy; (d) a group R0; (e) a group R a; (f) a group Rlb; (g) a group Rlc; (h) a group Rld; and 0) 2,6-difluorophenylamino ; wherein R )0υ, r R> llaa, T Rj I1bD, T R) I1cC, r R> Iidα, r R?2zaa, r R>22bD and RJ are as defined in the claims. The compounds have activity as inhibitors of cdk kinase (such as cdkl or cdk2) and glycogen synthase kinase-3 activity.